Skip to content

New drug holds out promise of long-term control or even cure of HIV

Many people living with HIV willing to take part in cure research, despite its risks

Early antiretroviral treatment reduces, but does not eliminate HIV reservoir

Jonathan Li presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Experimental agents reverse HIV latency and help immune system fight HIV-infected cells

James Whitney presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

We may need to combine many approaches to achieve a cure, delegates hear

Elite controllers may pay a high price for their low viral load

British HIV cure survey: most respondents would be prepared to take some health risk to help find a cure for HIV

Research for Prevention conference opens with real hope for an HIV vaccine

Novel immune-suppressant vaccine completely blocks HIV infection in monkeys: human trials planned